Frontiers in Microbiology (Nov 2018)

Whole Genome Sequencing of Influenza A and B Viruses With the MinION Sequencer in the Clinical Setting: A Pilot Study

  • Kazuo Imai,
  • Kazuo Imai,
  • Kazuo Imai,
  • Kaku Tamura,
  • Tomomi Tanigaki,
  • Mari Takizawa,
  • Eiko Nakayama,
  • Takahiko Taniguchi,
  • Misako Okamoto,
  • Yasumasa Nishiyama,
  • Norihito Tarumoto,
  • Norihito Tarumoto,
  • Kotaro Mitsutake,
  • Kotaro Mitsutake,
  • Takashi Murakami,
  • Takashi Murakami,
  • Shigefumi Maesaki,
  • Shigefumi Maesaki,
  • Takuya Maeda,
  • Takuya Maeda

DOI
https://doi.org/10.3389/fmicb.2018.02748
Journal volume & issue
Vol. 9

Abstract

Read online

Introduction: Whole genome sequencing (WGS) of influenza viruses is important for preparing vaccines and coping with newly emerging viruses. However, WGS is difficult to perform using conventional next-generation sequencers in developing countries, where facilities are often inadequate. In this study, we developed a high-throughput WGS method for influenza viruses in clinical specimens with the MinION portable sequencer.Methods: Whole genomes of influenza A and B viruses were amplified by multiplex RT-PCR from 13 clinical specimens collected in Tokyo, Japan. Barcode tags for multiplex MinION sequencing were added with each multiplex RT-PCR amplicon by nested PCR with custom barcoded primers. All barcoded amplicons were mixed and multiplex sequencing using the MinION sequencer with 1D2 sequencing kit. In addition, multiplex RT-PCR amplicons generated from each clinical specimen were sequenced using the Illumina MiSeq platform to validate the performance of MinION sequencer. The accuracy, recall, and precision rates of MinION sequencing were calculated by comparing the results of variant calling in the Illumina MiSeq platform and MinION sequencer.Results: Whole genomes of influenza A and B viruses were successfully amplified by multiplex RT-PCR from 13 clinical samples. We identified 6 samples as influenza type A virus H3N2 subtype and 7 as influenza B virus Yamagata lineage using the Illumina MiSeq platform. The overall accuracy, recall, and precision rates of the MinION sequencer were, respectively 99.95%, 89.41%, and 97.88% from 1D reads and 99.97%, 93.28%, and 99.86% from 1D2 reads.Conclusion: We developed a novel WGS method for influenza A and B viruses. It is necessary to improve read accuracy and analytical tools in order to better utilize the MinION sequencer for real-time monitoring of genetic rearrangements and for evaluation of newly emerging viruses.

Keywords